KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

CPEAR’s poll is a thinly veiled attempt to persuade policymakers to take a broadly popular issue in a less popular direction.

R.J. Reynolds Vapor Co.’s Vuse remains the top-selling e-cigarette brand with a 34.9% market share, while Geek Bar Pule by ...

The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exit ...

Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's authorization noted the pouches ...

S&P 500 surges in H1 2025; explore AI leaders & ETFs for H2. Click to learn more about stocks to avoid and tips to navigate ...

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...

All the latest breaking news on Food and Drug Administration. Browse Newsweek archives of photos, videos and articles on Food and Drug Administration.

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Axios Visuals It's not food, it's not chewing tobacco and it's not gum — though it might look like it when you see it — but it is becoming America's new addictive obsession. Why it matters: Sales of ...

Altria's dominant U.S. market share, strong pricing power, and brand loyalty provide a robust moat despite declining ...

Tobacco giant Altria Group is launching a plan to streamline and modernize operations that will involve an unspecified number of layoffs, the Henrico County-based Fortune 500 company disclosed.